• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ILMN

ILMN

Illumina, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD170.93

+8.38 (+5.16%)

Rating:B+

Company Profile

CEO

Jacob Thaysen

IPO Date

2000-07-28

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$162.60

Prev. Close

$162.55

Day Low

$160.10

Day High

$172.49

52W Low

$81.76

52W High

$172.49

Market Cap

$25.86B

Volume

3.12M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

65.0%

Avg Negative

2.8%

Avg Neutral

32.3%

News Feed

Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research

prnewswire.com·5/28/2026·↑ positive

Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research

prnewswire.com·5/28/2026·↑ positive

David P. King elected to Illumina's Board of Directors

prnewswire.com
·5/21/2026
·↑ positive

Is This the Right Time to Retain ILMN Stock in Your Portfolio?

zacks.com·5/20/2026·↑ positive

Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact

prnewswire.com·5/19/2026·↑ positive

ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View Up

zacks.com·5/1/2026·↑ positive

Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript

seekingalpha.com·4/30/2026·↓ negative

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

zacks.com·4/30/2026·↑ positive

Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates

zacks.com·4/30/2026·↑ positive

Illumina Reports Financial Results for First Quarter of Fiscal Year 2026

prnewswire.com·4/30/2026·↑ positive